Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease.
Parikh NR, Huiza C, Patel JS, Tsai S, Kalpage N, Thein M, Pitcher S, Lee SP, Inouye WS, Jordan ML, Sanati H, Jafari L, Bennett CJ, Gin GE, Kishan AU, Reiter RE, Lewis M, Sadeghi A, Aronson WJ, Garraway IP, Rettig MB, Nickols NG.
Parikh NR, et al. Among authors: jordan ml.
BMC Cancer. 2019 Apr 1;19(1):291. doi: 10.1186/s12885-019-5496-5.
BMC Cancer. 2019.
PMID: 30935383
Free PMC article.